2018
$156M
from 12 investors over 12 rounds
Quell Therapeutics raised $156M on November 29, 2021
Investors: SV Life Sciences, Tekla Capital Management, Syncona Limited, Monashee Investment Management LLC, JEITO, British Patient Capital, Ridgeback Capital Management LLC and Point72 Asset Management
Quell Therapeutics raised $40M on February 11, 2021
Investors: UCL Technology Fund and Syncona Limited
Quell Therapeutics raised $45M on May 20, 2019
Investors: UCL Technology Fund and Syncona Limited